Abstract
Cannabis sativa L. is one of the oldest cultivated crops, used in medicine for millennia due to therapeutic characteristics of the phytocannabinoids it contains. Its medicinal properties are highly influenced by the chemotype, that is, the ratio of the two main cannabinoids cannabidiol (CBD) and Δ-9-tetrahydrocannabinol (THC). Based on published data, the chemotype should correlate with plant morphology, genetics, and photosynthetic properties. In this work, we investigated leaf morphology, plant growth characteristics, cannabinoid profiles, THCAS gene sequences, and plant photosynthetic traits in two breeding populations of medical cannabis (MX-CBD-11 and MX-CBD-707). The populations differed significantly in morphological traits. The MX-CBD-11 plants were taller, less branched, and their leaves had narrower leaflets than the bushier, wideleaved MX-CBD-707 plants, and there were significant differences between populations in the dry biomass of different plant parts. Based on these morphological differences, MX-CBD-11 was designated as a narrow leaflet drug type or vernacular “Sativa” type, while MX-CBD-707 was classified as wide leaflet drug type or “Indica” type. Chemical characterisation revealed a discrepancy between the expected chemotypes based on plant morphology; although both populations have high CBD, within each Type II (CBD/THC intermediate) and Type III (CBD dominant) plants were detected. The THCAS gene sequence analysis clustered the plants based on their chemotypes and showed high similarity to the THCAS sequences deposited in NCBI. In silico complementary analysis, using published molecular markers for chemotype determination, showed their low discrimination power in our two populations, demonstrating the genotype dependence of the molecular markers. Basic photosynthetic traits derived from light and CO2 response curves were similar in the populations. However, measurements of gas exchange under chamber conditions revealed higher stomatal conductivity and photosynthesis in MX-CBD-707 plants, which were also characterised by higher day respiration. The results of this study showed that based on visual appearance and some morphological measurements, it is not possible to determine a plant’s chemotype. Visually homogenous plants had different cannabinoid profiles and, vice versa, morphologically distinct plants contained similar CBD and THC content. The two chemotypes identified in our experimental plants therefore did not correlate with plant visual appearance, leaf morphometry, and photosynthetic properties of the populations studied. Correlation was only demonstrated with the respect to THCAS sequences, which showed great discrimination power between the chemotypes.
Highlights
Cannabis (Cannabis sativa L.) is gaining popularity in the modern world through industrial, food, cosmetic, and medicinal uses
Because the results showed a uniform morphology within the populations alongside contrasting cannabinoid contents, we further analysed the genetic basis of the observed chemical differences by sequencing their tetrahydrocannabinolic acid (THCA) synthase (THCAS) genes
They were studied as part of the project ‘Breeding medical cannabis (Cannabis sativa L.)’, which is a collaboration between the Biotechnical Faculty of the University of Ljubljana and MGC Pharma Ltd. (United Kingdom)
Summary
Cannabis (Cannabis sativa L.) is gaining popularity in the modern world through industrial, food, cosmetic, and medicinal uses. The most widely cultivated group is “hemp” (“fibre-type hemp,” “industrial cannabis”), which was once an important crop for the production of raw materials for textiles and ropes and which is currently experiencing a revival after a steady decrease in its acreage after World War II (Tang et al, 2017). It is grown for seeds and fibre, food and beverage production, substances for cosmetic use, animal feed, and other industrial uses. In European countries, for example, the threshold is set at 0.2% or 0.3% THC in the upper third of the dried plant or in an upper 30 cm of dried plants shoots containing at least one female inflorescence (Regulation EU No 809/2014)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.